Literature DB >> 2078590

Conformation in solution of yeast tRNA(Asp) transcripts deprived of modified nucleotides.

V Perret1, A Garcia, J Puglisi, H Grosjean, J P Ebel, C Florentz, R Giegé.   

Abstract

A synthetic gene of yeast aspartic acid tRNA with a promoter for phage T7 RNA polymerase was cloned in Escherichia coli. The in vitro transcribed tRNA(Asp) molecules are deprived of modified nucleotides and retain their aspartylation capacity. The solution conformation of these molecules was mapped with chemical structural probes and compared to that of fully modified molecules. Significant differences in reactivities were observed in Pb2+ cleavage of the RNAs and in modification of the bases with dimethyl sulphate. The most striking result concerns C56, which becomes reactive in unmodified tRNA(Asp), indicating the disruption of the C56-G19 base pair involved in the D- and T-loop interaction. The chemical data indicate that unmodified tRNA(Asp) transcripts possess a relaxed conformation compared to that of the native tRNA. This conclusion is confirmed by thermal melting experiments. Thus it can be proposed that post-transcriptional modifications of nucleotides in tRNA stabilize the biologically active conformations in these molecules.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2078590     DOI: 10.1016/0300-9084(90)90158-d

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  54 in total

1.  The peculiar architectural framework of tRNASec is fully recognized by yeast AspRS.

Authors:  J Rudinger-Thirion; R Giegé
Journal:  RNA       Date:  1999-04       Impact factor: 4.942

2.  Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers.

Authors:  X Wei; M Götte; M A Wainberg
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

3.  Export and transport of tRNA are coupled to a multi-protein complex.

Authors:  C Kruse; D K Willkomm; A Grünweller; T Vollbrandt; S Sommer; S Busch; T Pfeiffer; J Brinkmann; R K Hartmann; P K Müller
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

4.  A primordial RNA modification enzyme: the case of tRNA (m1A) methyltransferase.

Authors:  Martine Roovers; Johan Wouters; Janusz M Bujnicki; Catherine Tricot; Victor Stalon; Henri Grosjean; Louis Droogmans
Journal:  Nucleic Acids Res       Date:  2004-01-22       Impact factor: 16.971

5.  Efficient mischarging of a viral tRNA-like structure and aminoacylation of a minihelix containing a pseudoknot: histidinylation of turnip yellow mosaic virus RNA.

Authors:  J Rudinger; C Florentz; T Dreher; R Giegé
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

6.  Tertiary structure checkpoint at anticodon loop modification in tRNA functional maturation.

Authors:  Sakurako Goto-Ito; Takuhiro Ito; Mitsuo Kuratani; Yoshitaka Bessho; Shigeyuki Yokoyama
Journal:  Nat Struct Mol Biol       Date:  2009-09-13       Impact factor: 15.369

7.  Purine bases at position 37 of tRNA stabilize codon-anticodon interaction in the ribosomal A site by stacking and Mg2+-dependent interactions.

Authors:  Andrey L Konevega; Natalia G Soboleva; Valentin I Makhno; Yuri P Semenkov; Wolfgang Wintermeyer; Marina V Rodnina; Vladimir I Katunin
Journal:  RNA       Date:  2004-01       Impact factor: 4.942

8.  Fe.bleomycin as a probe of RNA conformation.

Authors:  C E Holmes; A T Abraham; S M Hecht; C Florentz; R Giegé
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

9.  The RNA sequence context defines the mechanistic routes by which yeast arginyl-tRNA synthetase charges tRNA.

Authors:  M Sissler; R Giegé; C Florentz
Journal:  RNA       Date:  1998-06       Impact factor: 4.942

10.  Tad1p, a yeast tRNA-specific adenosine deaminase, is related to the mammalian pre-mRNA editing enzymes ADAR1 and ADAR2.

Authors:  A Gerber; H Grosjean; T Melcher; W Keller
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.